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Abstract 
Studies in rats, involving hippocampal lesions and hippocampal drug infusions, have implicated the 
hippocampus in the modulation of anxiety-related behaviors and conditioned fear. The ventral 
hippocampus is considered to be more important for anxiety- and fear-related behaviors than the 
dorsal hippocampus. In the present study, we compared the role of dorsal and ventral hippocampus 
in innate anxiety and classical fear conditioning in Wistar rats, examining the effects of temporary 
pharmacological inhibition by the GABA-A agonist muscimol (0.5 ug/0.5 ul/side) in the elevated 
plus maze and on fear conditioning to a tone and the conditioning context. In the elevated plus maze, 
dorsal and ventral hippocampal muscimol caused distinct behavioral changes. The effects of ventral 
hippocampal muscimol were consistent with suppression of locomotion, possibly accompanied by 
anxiolytic effects, whereas the pattern of changes caused by dorsal hippocampal muscimol was 
consistent with anxiogenic effects. In contrast, dorsal and ventral hippocampal muscimol caused 
similar effects in the fear conditioning experiments, disrupting contextual, but not tone, fear 
conditioning.  
 
Keywords: hippocampus, intracerebral infusion, anxiety, plus maze, conditioned fear, freezing, 
temporary inhibition, muscimol 
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1. INTRODUCTION 
Studies examining the effects of lesion or pharmacological manipulations of the hippocampus 
in rats have provided compelling evidence that the hippocampus is important for unconditioned 
anxiety/fear responses, as well as the formation and expression of conditioned fear responses to 
elemental (e.g., auditory) and contextual stimuli1 Moreover, the weight of evidence from studies 
using separate ventral or dorsal hippocampal manipulations suggests that the ventral hippocampus 
plays a rather general role in unconditioned anxiety and conditioned fear, whereas dorsal 
hippocampal contributions are more restricted to specific mnemonic aspects of fear conditioning, 
such as context learning; this is consistent with the ventral hippocampus featuring stronger direct 
connectivity to amygdala and hypothalamus, key components of the brain’s anxiety and fear circuit, 
whereas the dorsal hippocampus is more closely linked to parts of the entorhinal cortex that are 
implicated in visuo-spatial information encoding (Moser & Moser, 1998; Anagnostaras et al., 2001; 
Bast et al., 2001b; Kjelstrup et al., 2002; Bast et al., 2003; Bannerman et al., 2004; Maren & Holt, 
2004; Pentkowski, et al., 2006; Bast, 2007; Engin & Treit, 2007; Fanselow & Dong, 2010; Bast, 
2011). 
The present paper reports three experiments, in which we compared further the contributions 
of dorsal and ventral hippocampus to unconditioned anxiety and conditioned fear. We examined the 
effects of bilateral functional inhibition of neurons within dorsal or ventral hippocampus by local 
microinfusion of the GABA-A agonist muscimol (0.5 µg / 0.5 µl / side) on measures of 
unconditioned anxiety on the elevated plus maze (Experiment 1) and on the formation of 
conditioned fear (measured as freezing) to a tone or the conditioning context (Experiments 2 and 3). 
The elevated plus maze experiment (Experiment 1) addressed the hypothesis that ventral 
hippocampal muscimol would cause more pronounced anxiolytic effects than dorsal muscimol. This 
hypothesis is consistent with the idea that the ventral hippocampus plays a more important role in 
                                                 
1 Anxiety and fear both refer to responses to aversive stimuli and situations. Anxiety is more commonly used to refer to 
unconditioned, rather tonic, responses to more diffuse stimuli or situations associated with behavioral conflict and 
uncertainty, whereas fear commonly refers to rather phasic responses to stimuli associated with explicit danger 
(compare Gray and McNaughton, 2000, and Bannerman et al., 2004, and references therein). 
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unconditioned anxiety than the dorsal hippocampus, which is based on wide range of evidence 
Bannerman et al., 2004; Pentkowski, et al., 2006; Engin & Treit, 2007). More specifically, ventral 
cytotoxic lesions have been found to cause more pronounced anxiolytic effects than dorsal lesions 
on a variety of measures of innate anxiety, including elevated plus maze measures (Kjelstrup et al., 
2002; Bannerman et al., 2002, 2004), and ventral infusion of the local anaesthetic lidocaine (a 
sodium channel blocker inactivating neurons and fibers of passage) significantly increased the 
proportion of open-arm entries on the elevated plus maze test, whereas dorsal lidocaine had no 
significant effect (Bertoglio et al., 2006). Moreover, ventral, but not dorsal, hippocampal muscimol 
reduced unconditioned fear, as assessed by the shock-probe burying test (McEown and Treit, 2010). 
However, even though one study reported that dorsal hippocampal muscimol reduced measures of 
unconditioned anxiety on the elevated plus maze (Rezayat et al., 2005), the effects of dorsal and 
ventral hippocampal muscimol infusions on the elevated plus maze remain to be compared directly. 
Furthermore, in the present study, the effects of dorsal and ventral hippocampal muscimol infusions 
are examined alongside the effects of these manipulations on fear conditioning (Experiments 2 and 
3), allowing a direct comparison. In the fear conditioning experiments (Experiment 2 and 3), we 
aimed to corroborate our previous finding that ventral hippocampal muscimol (1 µg / 0.5 µl / side) 
disrupts contextual, but not tone, fear conditioning (Bast et al., 2001a) and to extend this finding by 
demonstrating similar effects of dorsal hippocampal muscimol. Such an outcome would be 
consistent with the idea that contextual fear conditioning requires dorsal hippocampal mechanisms 
mediating the formation of context representations, and ventral hippocampal mechanisms relating 
the context representations to fear processing via subcortical structures, including the amygdala 
(Maren and Fanselow, 1995; Anagnostaras et al., 2001; Bast et al., 2001a; Bast et al., 2003; 
Bannerman et al., 2004; Fanselow & Dong, 2010). While the ventral hippocampus has also been 
implicated in tone fear conditioning (Bast et al., 2001b; Bannerman et al., 2004), ventral 
hippocampal muscimol did not significantly reduce tone fear conditioning in our previous study 
(even though there was a numerical reduction), and we argued that partial inhibition of neuronal 
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activity in the ventral hippocampus via GABA-A receptor stimulation may not sufficiently interfere 
with ventral hippocampal processing to affect tone fear conditioning (in contrast, more general 
ventral hippocampal inactivation by the sodium channel blocker tetrodotoxin markedly impaired 
tone fear conditioning) (Bast et al., 2001a). Following our initial 2001 study (Bast et al., 2001a), a 
number of studies examined the effects of hippocampal muscimol infusions on fear conditioning, 
with somewhat discrepant outcomes.  Maren & Holt (2004) reported that ventral hippocampal 
muscimol (0.25 µg / 0.25 µl / side) disrupted tone, but not contextual (background), fear 
conditioning, whereas dorsal infusions had no effect. Consistent with two main findings by Maren 
& Holt (2004), additional studies reported that dorsal hippocampal muscimol (0.5 µg / 0.5 µl / side; 
Matus-Amat et al., 2004) and muscimol infusion into the ventral hippocampus (subiculum; 0.5 µg / 
1 µl / side; Biedenkapp and Rudy, 2008) did not cause anterograde contextual fear conditioning 
deficits. Such absence of anterograde contextual fear conditioning deficits following hippocampal 
muscimol (and also lesions) was explained by the competition hypothesis (Maren et al., 1997; 
Biedenkapp and Rudy, 2008; Fanselow, 2010). This hypothesis suggests that, while hippocampal 
mechanisms are normally important for contextual fear conditioning, they compete with an extra-
hippocampal system that can also support contextual fear conditioning, albeit less efficiently; the 
hippocampus normally suppresses the alternative system, but this suppression is released during 
hippocampal inactivation or inhibition, so that the extra-hippocampal system can support contextual 
fear conditioning. Most recently, however, Esclassan et al. (2009) reported that ventral hippocampal 
muscimol (0.25 µg /0.25 µl / side) disrupted both tone and contextual fear conditioning, whereas 
dorsal muscimol selectively reduced contextual fear conditioning, and Wang et al. (2012) also 
reported that dorsal hippocampal muscimol (0.5 µg / 0.5 µl / side) impaired contextual fear 
conditioning (Wang et al., 2012). Considering the different findings made in different laboratories, 
we found it important to re-examine the anterograde effects of ventral hippocampal muscimol 
infusions (Bast et al., 2001a) and to compare directly the effects of ventral and dorsal hippocampal 
muscimol on fear conditioning in our laboratory. 
 5
  
 
2. MATERIALS AND METHODS 
 
2.1. Subjects 
A total of 40 adult male Wistar rats (Zur:WIST[HanIbm], Research Unit Schwerzenbach, 
Schwerzenbach, Switzerland), weighing about 250 g and aged about 2 to 3  months at the time of 
surgery, were used in this study. They were housed in groups of four per cage under a reversed 
light-dark cycle (lights on: 19:00-07:00) in a temperature (21 ± 1°C) and humidity (55 ± 5%) 
controlled room. All animals were allowed free access to food and water. Eighteen rats received 
bilateral implantation of guide cannulae aiming at the dorsal hippocampus and twenty-two rats 
received bilateral implantation of guide cannulae aiming at the ventral hippocampus. After surgery, 
all rats were caged singly. Starting one day before surgery and throughout the study, all rats were 
handled daily. Behavioural testing was carried out in the dark phase of the cycle, between 9 and 18 
h. Principles of laboratory animal care (NIH publication no. 86-23, revised 1985) and Swiss 
regulations for animal experimentation were followed. 
 
2.2. Apparatus & Procedures 
2.2.1. Surgery 
Rats were anesthetized (i.p.) with Nembutal (sodium pentobarbital, Abbott Labs, North 
Chicago, IL; 50mg/kg body weight), together with a mixture of midazolam hydrochloride 
(Dormicum®, Hoffman–LaRoche, Switzerland; 2 mg/kg body weight) and medetomidin 
hydrochloride (Dormitor, Orion Corporation, Espoo, Finland; 0.15 mg/kg body weight) given 
intramuscularly. Then their head was placed in a Kopf stereotaxic frame. After application of a 
local anesthetic (lidocaine), the scalp was incised to expose the skull. Bregma and lambda were 
aligned in the same horizontal plane. A small hole (1.5 mm in diameter) was drilled on each side of 
the skull to reveal the dura covering the cortex overlying the hippocampus. Stainless steel guide 
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cannulae (26 gauge, 9 mm or 7 mm for ventral or dorsal hippocampus, respectively) in a custom-
made Perspex holder were implanted bilaterally into the brain aiming above the ventral (-5.2 mm 
posterior and ±5.0 mm lateral to bregma, and -5.0 mm ventral to dura) or dorsal (-3.0 mm posterior 
and ±1.5 mm lateral to bregma, and -2.5 mm ventral to dura) hippocampus, using the same 
coordinates as in previous studies (Bast et al., 2001a; Zhang et al., 2002a, 2002b; Bast et al., 2003). 
The guide cannulae were fixed to the skull with three anchoring skull screws and dental cement. 
Stainless steel stylets (34 gauge) extending 0.5 mm beyond the tips of the guide cannulae were 
placed inside the guide cannulae to prevent occlusion. After surgery, rats were allowed to recover 
for five days during which the experimenter gave the rat daily health checks and gentle handling, 
and replaced missing stylets. The behavioral procedures started five days after surgery. 
 
2.2.2. Hippocampal drug infusions 
Muscimol [C4H6N2O2(1/2 H2O); Tocris, Bristol, UK] was dissolved in 0.9% saline to obtain 
solutions with a concentration of 0.5 µg/0.5 µl for bilateral intracerebral infusion on the day of 
infusion. This dose, which is half the dose used in our previous fear conditioning experiments 
involving ventral hippocampal infusion (Bast et al., 2001a), was chosen based on watermaze studies 
where infusion into dorsal or ventral hippocampus caused significant impairments (Zhang et al., 
unpublished data) and because it caused only a moderate reduction of locomotor activity following 
ventral hippocampal infusion, whereas 1 µg per side caused very pronounced locomotor 
suppression (Bast et al., 2001a).  Infusions of 0.5 µl of 0.9 % saline were used as control. 
For the intracerebral infusion, rats were manually restrained, the stylets removed carefully, and 
infusion cannulae (34 gauge, stainless steel) were inserted into the brain through the previously 
implanted guide cannulae. The tips of the infusion cannulae protruded 1.5 mm beyond the tip of the 
guide cannulae into the hippocampus. Thus, the final dorso-ventral coordinate for the ventral and 
dorsal hippocampus was 6.5 mm and 4.0 mm below the dura, respectively, as in previous studies 
(Bast et al., 2001a; Zhang et al., 2002a, b; Bast et al., 2003). The infusion cannulae were connected 
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to 10-µl Hamilton microsyringes by flexible polyetheretherketone (PEEK) tubing. The syringes 
were mounted on a Kds micro-infusion pump. All rats were infused bilaterally with an infusion 
volume of 0.5 µl/side, delivered at the rate of 0.5 µl/min. Afterwards, the infusion cannulae were 
kept in place for an additional 60 s to allow for absorption of the infusion bolus before being 
replaced by the stylets. Using a small infusion volume (0.5 µl) and fine infusion cannulae (34 g) as 
in the present study, the infused drug is estimated to spread 1 mm or less in any direction (Myers, 
1966). While one study suggested that the spread of muscimol may be quite wide-spread following 
infusion  into the nucleus basalis magnocellularis or the reticular nucleus of the thalamus (Edeline 
et al., 2002), recent studies using infusion of fluorescent muscimol into prefrontal cortex (Allen et 
al., 2008) or into dorsal and ventral hippocampus (Jacobs et al., 2013) with doses and infusion 
volumes similar to the present study suggested that spread of muscimol is largely restricted to 0.5-1 
mm. In addition, the densely packed fiber bundles surrounding the hippocampus also seem to 
prevent diffusion out of the hippocampus (Morris et al., 1998). Behavioral testing began 5 min after 
replacement of the stylets. Our previous experiments indicate that, by this time, hippocampal 
muscimol infusion exerts significant behavioral (locomotor) effects which last for at least 60 min 
(Bast et al., 2001a; Bast & Feldon, 2003). 
 
2.2.3. Apparatus for behavioral testing 
2.2.3.1. Elevated plus maze.  
The maze was constructed of black-painted wood with four elevated arms raised by a single 
central support to a height of 62 cm above the floor. It was arranged as a cross with two open arms 
(45 cm × 10 cm) facing each other, and two other arms enclosed by high walls (45 cm x 10 cm x 40 
cm). The four arms extended from a common central platform (10 x 10 cm). Ridges of 0.5 cm 
bordering the open arms were added to provide an additional grip. The illumination above the 
central platform was around 20 lx. Behavior on the maze was recorded by a video camera mounted 
on the ceiling above the center of the maze and relayed to a monitor and a Video tracking Motion 
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Analysis and Behaviour Recognition System (EthoVision®, Noldus, Wageningen, The 
Netherlands). The maze was divided into five areas, one for each arm and one for the center (central 
platform). Equipment programming and data recording were controlled by a PC computer. 
2.2.3.2. Fear conditioning.  
Behavioral tests of conditioned freezing behavior were conducted in four shock chambers 
(Habitest; Coulborn Instruments, Allentown, PA) and four no-shock plexiglas cylinders (diameter, 
29cm; height, 28cm) enclosed in ventilated sound-attenuating boxes. Shock chambers were used for 
conditioning and context-test sessions, while the no-shock cylinders were used for the tone test 
sessions. Shock chambers were fitted with a parallel grid shock floor (16 parallel bars; E10-10RF; 
Coulborn Instruments), through which scrambled shocks could be delivered. These chambers had 
two side walls of aluminum and a rear and front wall of clear Perspex. A brown empty waste tray 
was situated below the grid floor. The four no-shock cylinders were fitted with a lattice grid and a 
brown waste tray was situated below the lattice grid. Waste trays, grids and chambers were cleaned 
with wet paper towels between rats and sessions. All testing in the no-shock cylinders was 
conducted with a house light on (1.12 W, light level in the no-shock cylinders, 1.5 lx); however, the 
shock chambers were not illuminated. The four shock boxes and the four no-shock cylinders were 
placed in two different rooms. Delivery of electric foot shock were controlled by a PC computer 
with dedicated software (S. Frank, Psychology Department, University of Tel Aviv, Israel) 
connected to a Coulborn Universal Environment Interface (E91-12) with Coulborn Universal 
Environment Port (L91-12). Shocks were delivered with a Coulbourn Precision Animal Shocker 
(E13-12) which generated bipolar rectangular 10-ms current pulses with a frequency of 10 Hz. 
Background noise was provided by a ventilation fan affixed to the light- and sound-attenuating 
chambers during all sessions. A monochrome minivideo camera with a wide angle (100°) 2.5-mm 
lens (VPC-465B; CES AG, Zurich, Switzerland) was attached to the center of the ceiling of each 
operant chamber. Four infrared (875 nm) light-emitting diodes (HSDL-4220; Hewlett Packard) 
positioned in the ceiling of each operant chamber provided light sufficient for camera function. 
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Throughout all sessions, images from each of the four shock or no-shock cylinders, respectively, 
were provided by these cameras, integrated into a four-quarter single image (100000 pixels) by a 
multiplexer (DX216CE, Sony), and recorded by a video-recorder (SVT1000; Sony). The video 
images were transferred to a PC computer equipped with an analysis program 
(Image; http://rsb.info.nih.gov/nih-image) and a macroprogram (P Schmid, Behavioral 
Neurobiology Laboratory, Swiss Federal Institute of Technology Zurich) to carry out automated 
analysis of freezing by comparing adjacent 1-s frames of videotape. Total immobility except 
respiratory movements is measured as freezing by our automated system. The validation and 
principle of the automated analysis of freezing behavior has been described in previous publications 
(Richmond et al., 1999). 
 
2.3. Experimental design and procedures for behavioral testing 
2.3.1. Experiment 1: Effects of muscimol infusion into the dorsal or ventral hippocampus 
on the elevated plus maze.  
A total of 21 rats were tested individually on the plus-maze. The infusion groups were as 
follows: Saline (n=9, five into ventral and four into dorsal hippocampus), dorsal hippocampal 
muscimol (n=6) and ventral hippocampal muscimol (n=6). The rats were individually brought to the 
experimental room at least 20 min before the experiment started. Five minutes after infusion, rats 
were placed on the central platform facing one of the open arms and allowed to explore the maze 
for 15 min, during which the rats’ behavior was videotaped. The rat was then removed from the 
maze and returned to its home cage. The maze was carefully cleaned before the next rat was tested. 
Based on the videotape recordings, several parameters were measured. Time spent and distance 
moved on the open and closed arms was measured using Ethovision, and entries into open and 
closed arms were scored by the experimenter when the rat entered its four paws into the arm. 
Relative increases of open arm as compared to closed arm parameters are typically considered to 
reflect anxiolytic effects, whereas relative decreases in closed arm as compared to open arm 
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parameters are thought to reflect anxiogenic effects (Pellow, Chopin, File, Briley, 1985; Rodgers & 
Dalvi, 1997; for more recent studies combining the elevated plus maze with hippocampal 
manipulations: Kjelstrup et al., 2002; Bannerman et al., 2002; Rezayat et al., 2005; Bertoglio et al., 
2006).   
 
2.3.2. Fear conditioning experiments 
Two experiments were conducted to test the effects of muscimol infusion into the dorsal or 
ventral hippocampus on classical fear conditioning. Rats were tested in batches of four. The 
different testing boxes and the order of testing were counterbalanced among the experimental 
groups as far as possible.  
2.3.2.1. Experiment 2: Effects of muscimol infusion into the dorsal or ventral 
hippocampus on foreground contextual fear conditioning.   
One week after the elevated plus maze experiment, all 21 rats from the elevated plus maze 
experiment were used for a fear conditioning experiment involving contextual conditioning without 
tone presentation. They were assigned to either the saline or muscimol group, so as to match these 
groups with respect to the rats’ infusion history during the elevated plus maze experiment (i.e., half, 
or about half, of the rats in each group of the fear conditioning experiment had received muscimol 
during the elevated plus maze experiment, the other half had received saline.). The infusion groups 
were as follows: Saline (n=9, five ventral and four dorsal hippocampal infusions), dorsal 
hippocampal muscimol (n=6) and ventral hippocampal muscimol (n=6). In this experiment, 
conditioning was conducted without an auditory CS to achieve a strong association between the 
electrical foot shock and the contextual CS, i.e. the conditioning chamber where the rats received 
the foot shock. Conditioning started 5 min after completion of the infusions. For conditioning, rats 
were put in the shock boxes for a total of 21 min and 6 s and were exposed to six 1-s foot shocks 
(0.5 mA) separated by 3-min blocks between an initial and a final 3-min block. The proportion of 
time spent freezing was calculated for the seven 3-min blocks preceding and following the 1-s foot 
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shock. One day after conditioning, in the context test session, rats were tested for freezing to the 
contextual CS (shock boxes). For that purpose, rats were placed in the shock box for 8 min and the 
proportion of time spent freezing was calculated in 1-min time block. 
2.3.2.2. Experiment 3: Effects of muscimol infusion into the dorsal or ventral hippocampus 
on tone and background contextual fear conditioning. 
A total of 19 naïve rats were used for a fear-conditioning experiment involving simultaneous 
tone and contextual conditioning. The infusion groups were as follows: Saline (n=6, four ventral 
and two dorsal hippocampal infusions), dorsal hippocampal muscimol (n=6) and ventral 
hippocampal muscimol (n=7). For conditioning (Day 1), rats were put in the shock boxes (context 
A) for a total of 24 min and 6s and were exposed to six pairings of a 30s auditory CS [85 dB(A), 2.9 
kHz] and a 1s foot shock (0.5 mA), with the 1-s footshock being contiguous with the last 1 s of the 
auditory CS and pairings separated by 3min blocks between an initial and a final 3min block. Use of 
fixed, predictable, intervals between the unconditioned stimuli (e.g., foot shocks) has been 
suggested to minimize overshadowing of the conditioning context by the explicit CS (LoLordo et 
al., 2001); indeed, the present background contextual fear conditioning resulted in similar context 
freezing as the foreground contextual conditioning procedure in the previous experiment (compare 
Figs 3B and 4C).  The proportion of time spent freezing was calculated for the seven 3min blocks 
preceding and following the 30s CS and for the duration of each 30s CS. One day after 
conditioning, in the context test session (Day 2), rats were tested for freezing to the contextual CS. 
For that purpose, rats were placed in the shock box (context A) for 8 min, without presentation of 
the auditory CS or application of the foot shock. Two days after conditioning, in the tone test 
session (Day 3), rats were tested for freezing to the auditory CS. For that purpose, they were put in 
the no-shock cylinder (context B) for a total of 11 min. After initial 3 min, the auditory CS was 
presented for the remaining 8 min without the presentation of shock. During all the test sessions, the 
proportion of time spent freezing was calculated for each 1-min block.  
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2.4. Data analysis 
Statistical analyses were performed with the StatView software system (Abacus Concepts, 
Inc., Berkeley, CA, 1992). Data were first subjected to ANOVA, using groups as between-subjects 
factor and time as within-subjects factor. Post hoc comparisons were conducted using Fisher's 
protected least significant difference test. Significant differences were accepted at P < 0.05. All 
values are presented as means ± S.E.M.. Since the groups receiving ventral and dorsal hippocampal 
saline infusion did not differ in any experiment (all Fs < 1), data from these groups were collapsed 
into one control group (Saline) for the analysis presented in the Results section.  
ANOVA is based on the assumptions of normality and homoscedasticity (equal variance); as 
has been pointed out by statisticians, most real data only meet these assumptions to some degree 
(Glass et al., 1972; Judd et al., 1995). Data transformations may help to improve compliance with 
these assumptions (Judd et al., 1995; Osborne, 2002). However, freezing data are commonly 
analyzed using ANOVA without any prior transformation of data, even though some authors have 
applied data transformation (e.g., Esclassan et al., 2009). Similarly, many elevated plus maze 
studies use ANOVA without prior data transformation (e.g., Bertoglio and Carobrez, 2002; Rezayat 
et al., 2005; Pohorecky, 2008), even though some studies also use nonparametric tests (e.g., 
Bannerman et al., 2004) or data transformation prior to ANOVA (e.g., Bertoglio et al., 2006). 
Eyeballing the distributions of our data and F ratio tests for equal variance suggest that our data do, 
overall, not grossly violate the assumptions underlying ANOVA; the exceptions are distance moved 
in closed arms, which significantly violated the assumption of equal variance (mainly due to one 
outlier in the dorsal hippocampal muscimol group, which did not at all enter the closed arm during 
the first 5-min block of testing) and arm entries, which were noticeably skewed. Importantly, 
statisticians have highlighted that it is less important whether ANOVA assumptions are exactly met, 
but more important to consider what the consequences of such violations might be (Glass et al., 
1972). It is widely agreed that ANOVA is robust with respect to violations of the assumptions of 
normality and homoscedasticity, affecting type I and II errors only minimally (Glass et al., 1972; 
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Judd et al., 1995, Ann Rev Psychol). Furthermore, even though this is not widely realized, 
nonparametric tests rely on other strong assumptions, which may be difficult to verify or meet (Judd 
et al., 1995); common nonparametric tests are also unsuitable for multifactorial analysis (such as 
combined analysis of treatment and time effects, which is relevant in the present study). Moreover, 
transformations are also associated with problems and may confound data interpretation (Games, 
1984; Osborne, 2002). For these reasons, we chose ANOVA without data transformation as a 
suitable approach to provide a quantitative, albeit approximate, measure of the statistical reliability 
of our findings. 
  
2.5. Histology 
After completion of the behavioral experiments, the rats were deeply anesthetized with an 
overdose of 2.5 ml/kg Nembutal (sodium pentobarbital, 50 mg/ml, i.p.) and transcardially perfused 
with 0.9% saline, followed by 120 ml of 4% formalin (4°C) to fix the brain tissue. Brains were 
extracted from the skull, post-fixed in 4% formalin solution, and subsequently cut into 40-µm 
coronal sections on a freezing microtome. To verify the injection sites, every fifth section through 
the dorsal or ventral hippocampus was mounted on gelatine-treated slides and stained with cresyl 
violet. After staining, the sections were dehydrated through alcohol series, cleared with xylene, and 
coverslipped with Eukitt (Kindler, Freiburg, Germany). Subsequently, the sections were examined 
with a light microscope to verify the location of the tips of the infusion cannulae and marked on 
plates taken from the rat brain atlas of Paxinos and Watson (1998). 
 
3. RESULTS 
3.1. Histology 
In all 40 cannulated rats, the tips of the infusion cannulae were located in the targeted areas 
within the border of the dorsal or ventral hippocampus (Fig. 1). Visible tissue damage was 
restricted to the area immediately surrounding the guide and infusion cannulae.   
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                            ______________________ 
             Fig 1 about here   
     ______________________ 
 
3.2. Experiment 1: Distinct effects of muscimol infusion into the dorsal or ventral hippocampus 
on the elevated plus maze  
During the experiment, one ventral hippocampal muscimol rat fell off the maze and was, 
therefore, not included in the behavioral analysis, leaving final group sizes of: n= 6 for dorsal 
hippocampal muscimol, n= 5 for ventral hippocampal muscimol and n= 9 for saline infusions.  
Both ventral and dorsal hippocampal muscimol infusions reduced distance travelled within 
closed arms, and neither of the two manipulations affected entries into closed arms; interestingly, 
dorsal hippocampal muscimol increased time spent in the closed arms (mainly during the third 5-
min block of the test session), pointing toward an anxiogenic effect, whereas ventral hippocampal 
muscimol did not significantly affect this measure (Fig. 2, left panels). Dorsal hippocampal 
muscimol infusion also decreased distance moved within open arms and entries into open arms, 
supporting an anxiogenic effect, whereas ventral hippocampal muscimol did not affect these 
measures; neither dorsal nor ventral hippocampal muscimol infusion affected open arm time (Fig. 
2, right panels). A 3 x 3 ANOVA (group x 5-min block) of the distance moved in closed arms  
only yielded a significant main effect of group (F2, 17 = 7.32, P < 0.006), without an interaction (F4, 
34 < 1) or main effect (F2, 34 = 2.09, P = 0.14) involving 5-min block. Post hoc comparisons revealed 
that saline rats moved significantly more in the closed arms than rats infused with muscimol into the 
ventral hippocampus (P < 0.03) or the dorsal hippocampus (P < 0.003), with no difference between 
the two muscimol groups (P = 0.41). A 3 x 3 ANOVA of the entries into closed arms did not yield a 
significant effect of group (F2, 17 = 1.17, P = 0.33) or 5-min block (F2, 34 = 1.77, P = 0.10), nor an 
interaction between the two (F4, 34 < 1).  However, a 3X3 ANOVA of time spent in closed arms 
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revealed a significant interaction of group x 5-min block (F4, 34 = 5.1, P < 0.03). This reflected that 
during the third 5-min block, dorsal hippocampal muscimol increased time in the closed arms as 
compared to the two other groups, whereas groups did not differ during the first two 5-min blocks 
(Fig. 2, bottom panel, left, inset). In support of this interpretation, separate ANOVAs for each 5-
min block revealed a significant group effect during the third 5-min block (F2, 17 = 4.6, P < 0.03, but 
not during the first two 5-min blocks (F2, 17 < 1.7, P > 0.2). Post hoc comparisons showed a 
significantly higher time in the doral hippocampal muscimol group (48.8±7.0 s), as compared with 
the ventral hippocampal muscimol group (26.6 ±4.9 s, P < 0.02) and the saline group (32.3 s ±3.6, 
P < 0.03). The ventral hippocampal muscimol and the saline group did not differ (P = 0.45).  
Furthermore, a 3 x 3 ANOVA of the distance moved in open arms yielded a strong trend toward a 
main effect of group (F2, 17 = 3.02, P = 0.075), without an interaction (F4, 34 < 1) or main effect (F2, 
34 < 1) involving 5-min block. Post hoc comparisons showed that rats infused with muscimol into 
the dorsal hippocampus moved significantly less in the open arms than the saline group (P < 0.03) 
and also tended to move less than rats infused with muscimol into the ventral hippocampus (P = 
0.084); the latter two groups did not differ  (P = 0.8). Similarly, a 3 x 3 ANOVA (group x 5-min 
block) of the entries into open arms revealed a significant effect of group (F2, 17 = 4.35, P < 0.03), 
without an interaction (F4, 34 = 1.35, P = 0.43)  or main effect (F2, 34 < 1) involving 5-min block. 
Post hoc comparisons showed that rats infused with muscimol into the dorsal hippocampus entered 
open arms significantly less than the saline group (P < 0.02) or rats infused with muscimol into the 
ventral hippocampus (P < 0.03); the latter two groups did not differ from each other  (P = 0.98).  
ANOVA did not reveal a main effect or interaction involving group for open-arm time (F < 1.4, P > 
0.28). 
                           ______________________ 
             Fig 2 about here   
     ______________________ 
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The ratio of open arm entries to total entries (open arm + closed arm) may reflect anxiolytic or 
anxiogenic effects, respectively, relatively unconfounded by locomotor effects, because locomotor 
effects would affect open and closed arm entries similarly and, thus, have only little influence on 
the ratio. However, an analysis of ratios, as compared to a separate analysis of open arm and closed 
arm measures, also reduces overall sensitivity to treatment effects, because the ratio measure has a 
considerably larger variance than the separate measures; the latter reflects that the variances of both 
separate measures contribute to the variance of the ratio measure. In the present study, dorsal 
hippocampal muscimol numerically decreased the proportion of open arm entries (24.7+11.2%), 
whereas ventral hippocampal muscimol increased the proportion (41.2+7.1%), as compared to 
saline (33.1+3.9%), supporting opposite effects of dorsal and ventral hippocampal muscimol. 
However, in contrast to the separate analysis of open and closed arm entries (see above), a 3X3 
ANOVA of the ratio measure failed to reveal a significant effect of group, and there was also no 
interaction group X 5-min block (Fs < 1.1, Ps > 0.35). This is likely to reflect at least partially the 
relatively high relative variance of the ratio measure. 
 
3.3. Experiment 2: Muscimol infusion into the dorsal or ventral hippocampus reduces 
foreground contextual fear conditioning.   
In the first fear conditioning experiment, one dorsal hippocampal muscimol rat fell ill and had 
to be culled; therefore this rat was not included in the behavioral analysis, leaving final group sizes 
of n= 5 for dorsal hippocampal muscimol, n= 6 for ventral hippocampal muscimol and n=9 for 
saline.  
During the conditioning session, all groups spent a similar percentage of time freezing during the 
seven 3-min blocks preceding and following the 1-s foot shocks (Fig.3A). A 3 x 7 (group x time-
blocks) ANOVA of the percentage of time spent immobile yielded only a significant effect of the 
seven 3-min blocks (F6, 102 = 22.831, P < 0.0001), but neither an effect of groups (F2, 17 = 0.32, P > 
0.73) nor an interaction of groups and time-blocks (F12, 102 = 1.527, P > 0.12). The significant effect 
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of time-blocks reflected that in all groups freezing developed throughout the six applications of the 
1-s foot shock.  
During the context test, both dorsal and ventral hippocampal muscimol rats showed virtually 
no conditioned fear to the conditioning context, whereas the Saline rats exhibited conditioned 
freezing during the first 2-3 min (Fig. 3B). A 3 x 8 (groups x time-blocks) ANOVA of the 
percentage of time spent immobile revealed a significant interaction of groups and 1-min blocks 
(F14, 119 = 3.05, P < 0.001). This reflected that in the Saline group freezing gradually increased to a 
maximum throughout the first three 1-min blocks of the context test session, followed by a 
subsequent gradual decline in freezing (reflecting extinction), whereas the dorsal and ventral 
hippocampal muscimol rats exhibited virtually no freezing throughout the total 8 min. Separate 
ANOVAs for each 1-min block revealed a significant group effect during the third 1-min block (F2, 
17 = 4.99, P < 0.02; all other 1-min block F < 2.43, P > 0.11). Post hoc comparisons showed a 
significantly higher percentage of time spent freezing in the Saline group (32.41±10.03) as 
compared with the ventral hippocampal muscimol group (4.72 ±2.49, P < 0.03) and with the dorsal 
hippocampal muscimol group (0.67 ±0.41, P < 0.02). The two muscimol groups did not differ (P = 
0.75). 
                           ______________________ 
             Fig 3 about here   
     ______________________ 
3.4. Experiment 3: Effects of muscimol infusion into the dorsal or ventral hippocampus on 
background contextual fear conditioning and on tone fear conditioning  
During the conditioning session, all groups spent a similar percentage of time freezing during 
the six 30-s CS presentations (F2, 16 = 1.71, P > 0.21) or during the seven 3-min blocks preceding 
and following the CS presentations (F2, 16 = 1.13, P > 0.34; Fig. 4A, B). ANOVA of the percentage 
of time spent immobile yielded only a significant effect of the six CS presentations (F5, 80 = 10.33, P 
< 0.0001) and the seven 3-min blocks (F6, 96 = 16.69, P < 0.0001). There was no interaction of 
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groups and six CS presentations (F10, 80 = 1.51, P > 0.15) or the seven 3-min blocks (F12, 96 = 1.63, P 
= 0.095). This reflected that in all groups freezing increased similarly due to foot-shock applications.  
During the context text, both dorsal and ventral hippocampal muscimol groups appeared to 
exhibit less conditioned fear to the context (conditioning box) than the Saline rats (Fig. 4C), even 
though statistical analysis only partly supported this impression. A 3 x 8 (groups x time blocks) 
ANOVA of the percentage of time spent freezing during the total 8 min of the context session 
yielded a strong trend for a main effect of group (F2, 16 = 2.83, P = 0.08) and a significant main 
effect of time blocks (F7, 112 = 2.59, P < 0.02), without an interaction group x time (F14, 112 = 0.52, P 
= 0.91). Post hoc tests on the basis of the statistical trend for a group effect revealed that freezing in 
ventral hippocampal muscimol rats (4.73 ± 3.34) was significantly reduced as compared to the 
Saline group (30.49 ± 12.35; P < 0.05) (inset in Fig. 4C). Even though the DH-MUS group froze 
only about half as much (17.01 ± 5.84) as the Saline group, this difference failed to reach 
significance (P = 0.24). The two muscimol groups did not differ from each other (P > 0.27).  
During the tone test, all groups exhibited similar conditioned fear to the tone CS (Fig. 4D). 
During the 3 min preceding the tone CS presentation, freezing levels were very low in all groups 
with no difference between groups (F2, 16 = 0.64, P > 0.53). However, during the 8 min of tone CS 
presentation, all groups exhibited marked freezing, i.e., conditioned fear. A 3 x 8 (Group x time-
blocks) ANOVA of the percentage of time spent immobile during these 8 min yielded only a 
significant main effect of time-blocks (F7, 112 = 9.64, P < 0.0001), but neither a significant effect of 
group (F2, 16 < 1) nor an interaction of groups x 1-min blocks (F14, 112 < 1). The significant effect of 
time-blocks reflected an immediate increase of conditioned fear to a maximum due to the tone CS 
presentation at min 4–6 and a subsequent extinction of conditioned fear in all groups. 
                           ______________________ 
             Fig 4 about here   
     ______________________ 
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4. DISCUSSION 
In the elevated plus maze experiments, ventral and dorsal hippocampal muscimol infusions 
had distinct effects. Ventral hippocampal muscimol infusions decreased movement only on the 
closed arms, consistent with decreased locomotion found in a previous study (Bast et al., 2001a), 
but left open arm measures unaffected; the latter may reflect anxiolytic effects (which would 
increase movement in open arms) countering the locomotor suppressing effects of ventral 
hippocampal muscimol. In contrast, dorsal hippocampal muscimol decreased movement on both 
open and closed arms and selectively decreased entries into open arms and increased time spent in 
closed arms; given that dorsal hippocampal muscimol infusion did not decrease, but rather 
increased, locomotor activity in previous open-field experiments (Bast & Feldon, 2003), our 
elevated plus maze data indicate that dorsal hippocampal muscimol may have anxiogenic effects. In 
the fear conditioning experiments, both ventral and dorsal hippocampal muscimol impaired 
contextual fear conditioning (even thouth the effects of dorsal hippocampal muscimol were less 
reliable), whereas tone fear conditioning was unaffected. 
 
4.1. Distinct effects of ventral and dorsal hippocampal muscimol on the elevated plus maze 
Previous studies examining the effects of partial hippocampal lesions and temporary 
pharmacological inactivation on a range of tests of unconditioned anxiety suggested that both 
ventral and dorsal hippocampal inactivation may be anxiolytic, with the effects of ventral 
hippocampal manipulations tending to be more pronounced (Kjelstrup et al., 2002; Bannerman et al., 
2002, 2004; Rezayat et al., 2005; Bertoglio et al., 2006; Engin & Treit, 2007; McEown & Treit, 
2010). However, the effects of hippocampal manipulations on tests of anxiety, such as the elevated 
plus maze, show considerable variability across studies, depending on a variety of factors (see, for 
example, discussion in Bannerman et al., 2002). Two factors that may be particularly relevant 
concerning the present results are locomotor effects of the hippocampal manipulations and baseline 
anxiety levels. As to ventral hippocampal muscimol infusions, we found previously that this 
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manipulation decreases open-field locomotor activity (Bast et al., 2001a), consistent with the view 
that ventral hippocampal activity positively modulates locomotor activity possibly through its 
positive modulation of ascending dopamine systems (Bast and Feldon, 2003). A non-specific 
suppression of behavioral activity, as suggested by these open field findings, may account for the 
reduction in movement on closed arms. With respect to movement on or into open arms, the 
locomotor suppressing effects of ventral hippocampal muscimol infusion and its anxiolytic effects 
(which would increase movement in open arms) may cancel each other out, so that ventral 
hippocampal muscimol infusions do not change open arm parameters compared to saline infusions. 
In contrast, dorsal hippocampal muscimol does not suppress open field locomotor activity, but 
rather increases it, potentially reflecting deficits in habituation to the open field environment, which 
may rely on dorsal hippocampal spatial/contextual processing (Bast & Feldon, 2003; also compare 
Anagnostaras et al., 2001). Therefore, the reduction in locomotion on both open and closed arms of 
the elevated plus maze by dorsal hippocampal muscimol is unlikely to reflect a non-specific 
suppression of behavioral activity, but is more consistent with anxiogenic effects. The finding that 
dorsal hippocampal muscimol also reduced open arm, but not closed arm, entries, and increased 
closed arm time (albeit only during the last 5 min of the 15-min test session), but not time in open 
arms, also supports anxiogenic effects. Our findings contrast with a previous report that dorsal 
hippocampal muscimol increased open arm entries and time, alongside a numerical increase in 
locomotor counts (Rezayat et al., 2005). It is possible that the different findings reflect an 
interaction of baseline anxiety levels and the effects of dorsal hippocampal muscimol on locomotor 
activity. Thus, in our study higher baseline anxiety levels, due to procedural differences, may have 
prevented the expression of locomotor hyperactivity that may result from dorsal hippocampal 
muscimol infusion (Bast & Feldon, 2003), so that anxiogenic effects were detected; for example, 
we single-housed rats after surgery and tested them in their dark phase, whereas Rezayat et al. 
(2005) group housed rats and tested them in their light phase, both of which may have contributed 
to increased anxiety on the elevated plus maze as compared to the study by Rezayat et al. (2005) 
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(Hogg, 1996; Bertoglio and Carobrez, 2002; Pohorecky, 2008). In contrast, if baseline anxiety 
levels are lower, dorsal hippocampal muscimol may induce locomotor hyperactivity and this may 
contribute to the increase of entries to and time on open arms.  
Overall, while our findings are consistent with the idea that activity in the ventral hippocampus 
contributes to anxiety, the present effects of dorsal hippocampal muscimol infusion raise the 
possibility that dorsal hippocampal mechanisms may, under some circumstances, contribute to 
reduced anxiety. The latter may be related to the mnemonic functions of the dorsal hippocampus in 
the encoding and storage of episodic-like memory (Morris, 2006; Bast, 2007): for example it is 
possible that dorsal hippocampus-dependent episodic-like memories of safe experiences within the 
laboratory normally act to moderate anxiety-related behavior, such as on the elevated plus maze.  
 
4.2. Ventral and dorsal hippocampal muscimol impair contextual, but not tone, fear 
conditioning 
The weight of evidence from studies using partial hippocampal cytotoxic lesions or temporary 
inactivation suggests that both ventral and dorsal hippocampus play a role in forming conditioned 
fear memories, with the effects of dorsal hippocampal lesions or inactivation largely limited to 
contextual fear memory (Anagnostaras et al., 2001; Bast et al., 2001a, 2001b; Bannerman et al., 
2004; Maren & Holt, 2004; Pentkowski, et al., 2006; Esclassan et al., 2009).   
However, as outlined in the Introduction, there is substantial variability between effects 
reported by different studies, including studies using temporary functional inhibition by muscimol 
(also see discussion by Maren & Holt, 2004, and Esclassan et al., 2009). Importantly, in the present 
study, we replicated our previous findings that ventral hippocampal muscimol impairs contextual 
fear conditioning in both foreground and background procedures, while not significantly affecting 
tone fear conditioning (Bast et al., 2001a), and we showed similarly selective effects on contextual 
fear conditioning for dorsal hippocampal muscimol infusions. In the present study, the effects of 
dorsal hippocampal muscimol on contextual fear conditioning was not totally reliable, with this 
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effect failing to reach significance in Experiment 3; this is consistent with the variable results 
reported in the literature, with some studies reporting significant disruption of contextual fear by 
dorsal hippocampal muscimol (Esclassan et al., 2009; Wang et al., 2012), while others failed to find 
a significant effect (Maren & Holt, 2004; Matus-Amat et al., 2004). Interestingly, the selective 
impairment of contextual, but not tone, fear conditioning by hippocampal muscimol resembles the 
selective anterograde deficits in contextual fear conditioning following infusion of NMDA-receptor 
antagonists into the ventral (Zhang et al., 2001) or dorsal hippocampus (Bast et al., 2003; Schenberg 
and Oliveira, 2008). Given that stimulation of hippocampal GABA receptors inhibits NMDA 
receptor-dependent long-term potentiation (LTP) (Collingridge, 2003), it is possible that the 
selective deficits in contextual fear conditioning caused by muscimol stimulation of hippocampal 
GABA-A receptors reflect interference with LTP-like plasticity mechanisms.  
Which firm conclusions can we draw from these findings and which factors determine the 
effects of hippocampal muscimol infusions on fear conditioning? First, out of three studies (present 
study; Maren & Holt, 2004; Esclassan et al., 2009), not one study reported effects of dorsal 
hippocampal muscimol (0.5 µg / 0.5 µl / side in the present study, 0.25 µg / 0.25 µl / side in the 
other two studies) on tone fear conditioning, supporting that the dorsal hippocampus is not required 
for elemental fear conditioning. Second, the strength of fear conditioning may play a role in 
determining the effects of dorsal and ventral hippocampal muscimol infusions. Thus, both dorsal 
and ventral hippocampal muscimol infusions disrupted contextual fear conditioning when the 
resulting conditioned context fear in the control group was relatively moderate (20-50% freezing) 
(present study, Experiments 2 and 3, 0.5 µg / 0.5 µl / side; Esclassan et al., 2009, 0.25 µg / 0.25 µl / 
side), whereas neither dorsal nor ventral hippocampal muscimol infusions affected contextual fear 
conditioning when conditioning resulted in stronger conditioned freezing (50-70%) (Maren & Holt, 
2004, 0.25 µg / 0.25 µl / side; Matus-Amat et al., 2004, 0.5 µg / 0.5 µl / side; Biedenkapp and Rudy, 
2008, 0.5 µg / 1 µl / side) (with the exception of Wang et al. (2012), who reported anterograde 
context fear deficits following dorsal hippocampal muscimol (0.5 µg / 0.5 µl / side) with context 
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freezing levels of nearly 60%). That dorsal and ventral hippocampal muscimol infusions cause 
anterograde deficits in contextual fear conditioning, depending on the strength of the conditioing is 
consistent with the following view: i) contextual fear conditioning normally requires dorsal and 
ventral hippocampus (with dorsal hippocampus mediating the formation of contextual 
representations and ventral hippocampus relating these representations to fear processing via 
subcortical sites, such as the amygdala;  Maren and Fanselow, 1995; Anagnostaras et al., 2001; Bast 
et al., 2001a; Bast et al., 2003; Bannerman et al., 2004; Fanselow & Dong, 2010); ii) an alternative 
extra-hippocampal system can support contextual fear conditioning, but is less efficient than the 
hippocampus and, thus, is not able to sustain conditioning under more demanding circumstances, 
such as those that would result in weak contextual fear (Fanselow, 2010). The strength of 
conditioning may also partly determine whether or not ventral hippocampal muscimol infusions 
disrupt tone fear conditioning. Thus, in our experiments (present study, Experiment 2; Bast et al., 
2001a), tone fear conditioning resulted in higher levels of freezing than contextual fear conditioning 
and was not affected by ventral hippocampal muscimol infusions, whereas in the experiment by 
Maren & Holt (2004) tone fear conditioning was weaker than contextual fear conditioning and was 
disrupted by ventral hippocampal muscimol infusion (whereas contextual fear conditioning was 
not). However, Esclassan et al. (2009) reported very high levels of tone fear conditioning in their 
control condition (nearly 80% freezing) and yet found a marked disruption by ventral hippocampal 
muscimol. Thus, while the strength of conditioning may essentially determine whether dorsal and 
ventral hippocampal muscimol infusions disrupt contextual fear conditioning across studies, the 
effects of ventral hippocampal muscimol infusions on tone fear conditioning are less consistently 
linked to conditioning strength across studies. 
 
5. CONCLUSIONS 
On the elevated plus maze, the effects of ventral hippocampal muscimol infusion were 
consistent with a reduction in locomotor activity, possibly accompanied by anxiolytic effects. In 
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contrast, the effects of dorsal hippocampal inhibition by muscimol were more consistent with 
anxiogenic effects. Our fear conditioning experiments, corroborate that both ventral and dorsal 
hippocampus are required for contextual fear conditioning; a comparison with previous studies 
using dorsal and ventral hippocampal muscimol infusions suggests that this requirement may be 
limited to conditions normally resulting in moderate context fear. In addition, our fear conditioning 
data corroborate previous findings that dorsal hippocampal muscimol infusions do not affect tone 
fear conditioning. Finally, in our hands, ventral hippocampal muscimol infusions do not 
significantly affect tone fear conditioning (also see Bast et al., 2001a), contrasting with studies by 
other groups (and with our own finding of disrupted tone fear conditioning following ventral 
hippocampal inactivation by tetrodotoxin; Bast et al., 2001a). The reasons for the variable effects of 
ventral hippocampal inactivation on tone fear conditioning are not clear. 
 
 
Acknowledgements: This research was supported by grants from the Swiss National Science 
Foundation and the Swiss Federal Institute of Technology (ETH) Zurich. W.Z. is currently 
supported by Jiangsu University (Nr. 13JDG001). At the Laboratory for Behavioural Neurobiology, 
ETH, the authors thank the animal facility team for their care of the animals, Ms Liz Weber for her 
histology preparations, Mr. Peter Schmid for the design and maintenance of the computerized 
systems for behavioral analysis. 
 
 25
Reference 
Allen TA, Narayanan NS, Kholodar-Smith DB, Zhaoa Y, Laubach M and Brown TH (2008) 
Imaging the spread of reversible brain inactivations using fluorescent muscimol. J Neurosci 
Meth 171: 30-38 
Anagnostaras SG, Gale GD and Fanselow MS. (2001). Hippocampus and contextual fear 
conditioning: recent controversies and advances. Hippocampus 11: 8–17 
Bannerman DM, Deacon RM, Offen S, Friswell J, Grubb M and Rawlins JN, (2002) Double 
dissociation of function within the hippocampus: spatial memory and hyponeophagia, Behav 
Neurosci 116: 884–901  
Bannerman DM, Rawlins JNP, McHugh SB, Deacon RMJ,Yee BK, Bast T, Zhang WN, Pothuizen 
HHJ and Feldon J. (2004) Regional dissociations within the hippocampus-memory and 
anxiety. Neurosci Biobehav Rev 28: 273–83 
Bast T (2007) Toward an integrative perspective on hippocampal function - from the rapid encoding 
of experience to adaptive behavior. Rev Neurosci 18: 253-281 
Bast T (2011) The hippocampal learning-behavior translation and the functional significance of 
hippocampal dysfunction in schizophrenia. Curr Opin Neurobiol 21: 492-501 
Bast T, Zhang WN and Feldon J. (2001a) The ventral hippocampus and fear conditioning in rats: 
different anterograde amnesias of fear after tetrodotoxin inactivation and infusion of the 
GABAA agonist muscimol. Exp Brain Res 139:39–52 
Bast T, Zhang WN and Feldon J. (2001b) Hippocampus and classical fear conditioning.  
Hippocampus 11: 828-31 
Bast T, Zhang WN and Feldon J (2003) Dorsal hippocampus and classical fear conditioning to tone 
and context in rats: The effects of local NMDA-receptor blockade and stimulation, 
Hippocampus 13: 657-75 
Bast T, and Feldon J. (2003). Hippocampal modulation of sensorimotor processes. Prog Neurobiol 
70: 319-345 
 26
Bertoglio LJ, Carobrez AP (2002) Behavioral profile of rats submitted to session 1-session 2 in the 
elevated plus-maze during diurnal/nocturnal phases and under different illumination 
conditions. Behav Brain Res 132: 135-143 
Bertoglio LJ, Joca SR and Guimaraes FS. (2006) Further evidence that anxiety and memory are 
regionally dissociated within the hippocampus. Behav Brain Res 175: 183-8  
Biedenkapp JC and Rudy JW (2008) Hippocampal and extrahippocampal system compete for 
control of contextual: role of ventral subiculum and amygdala. Learn Memory 16: 38-45 
Collingridge GC (2003) The induction of N-methyl-D-aspartate receptor-dependent long-term 
potentiation. Philos Trans R Soc Lond B Biol Sci 358: 635–641 
Edeline JM, Hars B, Hennevin E and Cotillon N (2002) Muscimol diffusion after intracerebral 
microinjections: a reevaluation based on electrophysiological and autoradigraphic 
quantifications. Neurobiol Learn Mem 78: 100-124 
Engin E and Treit D (2007) The role of hippocampus in anxiety: intracerebral infusion studies. 
Behav Pharmacol 18: 365-74 
Esclassan F, Coutureau E, Di Scala G, Marchand AR (2009) Differential contribution of dorsal and 
ventral hippocampus to trace and delay fear conditioning. Hippocampus 19:33-44 
Fanselow MS (2010) From contextual fear to a dynamic view of memory systems. Trends Cogn Sci 
14: 7-15 
Fanselow MS and Dong HW (2010) Are the dorsal and ventral hippocampus functionally distinct 
structures? Neuron 65: 7-19 
Games PA (1984) Data transformations, power, and skew: A rebuttal to Levine and Dunlap. 
Psychol Bull 95: 345-347 
Glass GV, Peckham PD and Sanders JR (1972) Consequences of failure to meet assumptions 
underlying the fixed effects analyses of variance and covariance. Rev Educ Res 42: 237-288 
Gray J and McNaughton N (2000) The neuropsychology of anxiety: an enquiry into the functions of 
the septo-hippocampal system. 2nd Edition. Oxford: Oxford University Press. 
 27
Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal of 
anxiety. Pharmacol Biochem Behav 54: 21-30. 
Jacobs NS, Allen TA, Nguyen N, and Fortin NJ (2013) Critical role of the hippocampus in memory 
for elapsed time. J Neurosci 33: 13888-13893 
Judd CM, McClelland GH, Culhane SE (1995) Data analysis: continuing issues in the everyday 
analysis of psychological data. Ann Rev Psychol 46: 433-465 
Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, and Moser MB. (2002) Reduced 
fear expression after lesions of the ventral hippocampus. Proc Nat Acad Sci USA 99: 10825-
10830 
LoLordo VM, Williams DA, McPhee JE (2001) Overshadowing of situational cues with variable 
but not fixed intertrial intervals. Anim Learn Behav 29: 143-152 
Maren S, Aharonov G, Fanselow MS (1997) Neurotoxic lesions of the dorsal hippocampus and 
Pavlovian fear conditioning in rats. Behav Brain Res 88: 261-274 
Maren S and Fanselow MS (1995) Synaptic plasticity in the basolateral amygdala induced by 
hippocampal formation stimulation in vivo. J Neurosci 15: 7548-7564 
Maren S, Holt WG (2004) Hippocampus and Pavlovian fear conditioning in rats: muscimol 
infusions into the ventral, but not dorsal, hippocampus impair the acquisition of conditional 
freezing to an auditory conditional stimulus. Behav Neurosci 118: 97-110  
Matus-Amat P, Higgins EA, Barrientos RM, Rudy JW. (2004) The role of the dorsal hippocampus 
in the acquisition and retrieval of context memory representations. J Neurosci 24: 2431-9 
McEown K and Treit D (2010) Inactivation of the dorsal or ventral hippocampus with muscimol 
differentially affects fear and memory. Brain Res 1353: 145-51 
Morris RG, Halliwell RF, Bowery N (1998) Synaptic plasticity and learning II: do different kinds of 
plasticity underlie different kinds of learning? Neuropsychologia 27: 41-59. 
Morris RGM (2006) Elements of a neurobiological theory of hippocampal function: the role of 
synaptic plasticity, synaptic tagging and schemas. Eur J Neurosci 23: 2829-2846. 
 28
Moser MB, Moser EI (1998) Functional differentiation in the hippocampus. Hippocampus 8: 608–
619 
Osborne J (2002). Notes on the use of data transformations. Practical Assessment, Research & 
Evaluation 8: 1-8 
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated 
-maze as a measure of anxiety in the rat. plus J Neurosci Methods 14: 149-67 
Pentkowski NS, Blanchard DC, Lever C, Litvin Y and Blanchard RJ. (2006) Effects of lesions to 
the dorsal and ventral hippocampus on defensive behaviors in rats. Eur J Neurosci 23: 2185–
2196. 
Pohorecky LA (2008) Psychosocial stress and chronic ethanol ingestion in male rats: effects on 
elevated plus maze behavior and ultrasonic vocalizations. Physiol Behav 94: 432-447. 
Rezayat M, Roohbakhsh A, Zarrindast MR, Massoudi R, Djahanguiri B (2005) Cholecystokinin and 
GABA interaction in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. 
Physiol Behav 84: 775-82 
Richmond MA, Yee BK, Pouzet B, Veenman L, Rawlins JNP, Feldon J, Bannerman DM. (1999) 
Dissociating context and space within the hippocampus: effects of complete, dorsal and ventral 
excitotoxic lesions on conditioned freezing and spatial learning. Behav Neurosci 113: 1189–
1203 
Rodgers RJ, Dalvi A. (1997) Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 
21: 801–810 
Schenberg EE, Oliveira MG. 2008. Effects of pre or posttraining dorsal hippocampus D-AP5 
injection on fear conditioning to tone, background, and foreground context. Hippocampus 
18:1089–1093 
Wang S-H, Finnie PSB, Hardt O, Nader K (2012) Dorsal hippocampus is necessary for novel 
learning, but sufficient for subsequent similar learning. Hippocampus 22:2157–2170  
 29
Zhang WN, Bast T, Feldon J (2001) The ventral hippocampus and fear conditioning: differend 
anterograde amnesias of fear after infusion of N-methyl-D-aspartate or its noncompetitive 
antagonist MK-801 into the ventral hippocampus. Behav Brain Res 126: 159-174 
Zhang WN, Bast T, Feldon J (2002a) Effects of hippocampal N-methyl-D-aspartate infusion on 
locomotor activity and prepulse inhibition: differences between the dorsal and ventral 
hippocampus. Behavioral Neuroscience 116: 72-84 
Zhang WN, Bast T, Feldon J (2002b) Prepulse inhibition in rats with temporary 
inhibition/inactivation of ventral or dorsal hippocampus. Pharmacology Biochemistry and 
Behaviour 73: 929-940 
 30
FIGURE LEGENDS 
 
Fig. 1   Infusion sites in the dorsal (A) and ventral (B) hippocampus. Photomicrograph of a coronal 
brain section with the tracks of the guide cannulas visible in both hemispheres (top) and 
approximate location of the tips of the infusion cannulae depicted on plates of coronal sections 
through the rat brain (Paxinos and Watson, 1998) (bottom). Values on the right represent distance in 
mm from bregma. The photomicrographs have been taken at an anterior-posterior level 
corresponding to approximately -3.6 mm (A) and -5.6 mm (B) from bregma in the atlas by Paxinos 
and Watson (1998). 
 
Fig. 2   Experiment 1: Effects of muscimol infusion into the dorsal or ventral hippocampus on the 
elevated plus maze. Rats were bilaterally infused with saline into dorsal or ventral hippocampus 
(0.5 µl/side; Saline, n=9) or with muscimol (0.5 µg/0.5 µl/side) into dorsal hippocampus (DH-
MUS, n=6) or into ventral hippocampus (VH-MUS, n=5) 5-min prior to the test. Top, Distance (cm) 
moved in the closed and open arms; middle, Entries into the closed or open arms; bottom, Time (s) 
spent in the closed or open arms; because of a significant interaction group x 5-min block of testing 
for time spent in closed arms (see Results, 3.2.), the inset shows values separately for each 5-min 
block (B1 to B3). Values show the average per 5-min block as mean+SEM; *P < 0.05 vs saline; §P 
< 0.02 vs ventral hippocampal muscimol.  
 
Fig. 3   Experiment 2: Effects of muscimol infusion into the dorsal or ventral hippocampus on 
foreground contextual fear conditioning. Rats were bilaterally infused with saline into dorsal or 
ventral hippocampus (0.5 µl/side; Saline, n=9) or with muscimol (0.5 µg/0.5 µl/side) into the dorsal 
(DH-MUS, n=5) or ventral hippocampus (VH-MUS, n=6) 5-min before conditioning. (A) 
Proportion of time spent freezing during the seven 3-min blocks preceding and following the six 1-s 
foot shocks in the conditioning session. (B) Proportion of time spent freezing during the eight 1-min 
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blocks of the context test session; *P < 0.05 vs VH-MUS and DH-MUS. All values show 
means+SEM. 
 
Fig. 4 Experiment 3: Effects of muscimol infusion into the dorsal or ventral hippocampus on 
background contextual fear conditioning and on tone fear conditioning. Rats were bilaterally 
infused with saline into dorsal or ventral hippocampus (0.5 µl/side; Saline, n=6) or with muscimol 
(0.5 µg/0.5 µl/side) into the dorsal (DH-MUS, n=6) or ventral hippocampus (VH-MUS, n=7) 5-min 
before conditioning. (A) Freezing during the six 30-s blocks of conditioned stimulus (CS) 
presentation in the conditioning session. (B) Freezing during the seven 3-min blocks preceding and 
following the CS presentations during the conditioning session. (C) Freezing during the eight 1-min 
blocks of the context test. The inset shows freezing per 1-min block, averaged across the 8-min test 
session to reveal the main effect of group. The asterisk indicates a significant difference from the 
Saline group. (D) Freezing during the three 1-min blocks preceding the CS presentation and the 
subsequent eight 1-min blocks of tone-CS presentation of the tone test. All values show 
means+SEM. 
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